COMMUNIQUÉS West-GlobeNewswire

Qu Biologics publishes potentially paradigm-shifting results of their first randomized-placebo controlled trial for the treatment of Crohn’s disease
23/07/2019
VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of microbial-based immunotherapies [...]
RadNet, Inc. Announces Date of its Second Quarter 2019 Financial Results Conference Call
23/07/2019
LOS ANGELES, July 23, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Transactions in relation to share buyback program
23/07/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
23/07/2019
- Final LRT BAL panel demonstrates overall weighted average sensitivity of up to 94.7% and overall weighted average specificity of up to 98.4% - Unyvero provides results after approximately five hours, compared to an [...]
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu® in Flu Care
23/07/2019
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu ® in Flu Care PARIS – July 23, 2019 – Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu ® [...]
Sanofi signe un accord stratégique en vue d’obtenir les droits exclusifs de Tamiflu® dans le traitement de la grippe, sur le marché américain de l’automédication
23/07/2019
Sanofi signe un accord stratégique en vue d’obtenir les droits exclusifs de Tamiflu ® dans le traitement de la grippe, sur le marché américain de l’automédication PARIS – Le 23 juillet 2019 - Sanofi a signé un accord [...]
Idorsia announces financial results for the first half of 2019
23/07/2019
Allschwil, Switzerland – July 23, 2019 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2019. Key figures US GAAP operating expenses HY 2019 at CHF 252 million Non-GAAP operating [...]
WW Schedules Second Quarter 2019 Earnings Conference Call
22/07/2019
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WW) will release its results for the second quarter 2019 after market close on Tuesday, August 6, 2019. WW will host a conference [...]
Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation
22/07/2019
CANTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company,” “we” or “our”) today announced that it has commenced an offer to exchange (“Offer to Exchange”) 0.095 shares of [...]
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
22/07/2019
CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 5, 2019. [...]
Silk Road Medical to Report Second Quarter 2019 Financial Results on July 29, 2019
22/07/2019
SUNNYVALE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results [...]
Genesis HealthCare to Release Second Quarter 2019 Results on August 8, 2019
22/07/2019
KENNETT SQUARE, Pa., July 22, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, July 23rd to Discuss Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and from Bioequivalence Study
22/07/2019
BRISBANE, Calif. and BASEL, Switzerland, July 22, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE:MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s [...]
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
22/07/2019
MENLO PARK, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced the closing of its previously announced public offering of 10,781,250 [...]
Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
22/07/2019
SOUTH SAN FRANCISCO, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that two preclinical poster presentations relating to CK-3773274 (CK-274) will be presented at the [...]
BioCorRx’s Director Louis Lucido Appeared Today on Yahoo Finance LIVE “On the Move”
22/07/2019
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders [...]
ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”
22/07/2019
EDISON, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast
22/07/2019
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical™ therapeutic [...]
Transactions in relation to share buyback program
22/07/2019
Announcement no. 43/2019 22 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]

Pages